Download CCG & Trust Reports

Sign-in for access to your CCG's reports

Latest News

This page features information on recent MTRAC activities. If you wish to receive an e-mail when new items are added, please register to join our mailing list.

Buy an early full-access subscription to MTRAC and subscriber-only materials: 

Want more?  Earlier access to guidance sheets and the supporting evidence reviews? New national MTRAC subscriptions available!  Please contact mtrac@keele.ac.uk for details and a free sample evidence pack.

Publication policy:

In recognition of the support of our Subscriber CCGs, the full content of MTRAC guidance sheets is restricted to Subscribers for a period of three months following publication.  An excerpt (the guidance box text) is publicly available during the period of restriction.  Following that period, the full guidance sheet will be publicly available.

Latest Verdicts published (excerpts available for public view.  For members of subscriber CCGs, please login to view the full text):

March 2018: new guidance

.

January 2018: new fulltext versions now available:

.

September 2017: new guidance

.

July 2017: new guidance 

.

June 2017: fulltext versions now available for:

.

March 2017: MTRAC gains NICE Accreditation for the Commissioning Guidance Summaries.  For full details please see the press release

March 2017: new and updated guidance

.

February 2017: new fulltext guidance

.

January 2017: new fulltext guidance

.

October 2016: new guidance 

.

August 2016: new full-text versions available:

.

July 2016: new and updated guidance

.

May 2016: new guidance extracts

.

May 2016 FULLTEXT VERSIONS NOW AVAILABLE: 

.

February 2016: Class review of ICS/LABA combined fixed-dose inhalers for the treatment of asthma

.

January 2016: horizon scanning guidance on products awaiting launch:

Now available:

.

September 2015: new guidance

.

August 2015: fulltext guidance available

.

Latest Committee Meeting:

The MTRAC committee last met on Thursday 18th January

  • Triple component inhalers for the treatment of chronic obstructive pulmonary disease (COPD)

.

Next Committee Meeting:

Products to be considered by MTRAC on Thursday 29th March

  • New licensed formulations of acetylcysteine for use as mucolytics in respiratory conditions

If you wish to request the review of a particular product please see the contact page for further details.

Please wait, loading files...
Document      

Download Selected